Hogan Lovells Our thinking banner

Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

News

FDA extends comment period for real-time clinical trials pilot, AI use in studies (updated)

01 June 2026

Insights and Analysis

EDPB Guidelines on processing personal data for scientific research – Key takeaways

28 May 2026

News

Drug repurposing: FDA seeks comments on how to address unmet medical needs

26 May 2026

News

MHRA publishes new draft rare disease therapies regulatory framework and consultation

21 May 2026

News

FDA AI tool Elsa 4.0 and HALO unveiled

08 May 2026

News

House committee report signals limits on foreign clinical data

06 May 2026

Insights and Analysis

Practical considerations for using AI in analyzing clinical data and preparing FDA submissions

30 April 2026

News

FDA draft guidance operationalizes animal testing phaseout

30 April 2026

Insights and Analysis

Trump promotes psychedelic drug availability but legal issues remain

24 April 2026

News

FDA signals heightened enforcement focus on ClinicalTrials.gov compliance

17 April 2026

News

FDA finalizes guidance on weight-loss devices: Five things manufacturers need to know

24 March 2026

Insights and Analysis

Life Sciences & Health Care Horizons 2026

11 March 2026

Load more

Digital Client Solutions

Empowering you to lead change through our digital solutions.